Status:
UNKNOWN
Venous Thromboembolism in Primary Pancreatic Tumour Resection
Lead Sponsor:
University of Thessaly
Conditions:
Venous Thromboembolism
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate the development of venous thromboembolism (VTE) and possible determinants in patients with primary pancreatic cancer undergoing pancreatic cancer resection.
Detailed Description
Cancer associated thrombosis (CAT) is the second cause of death, in oncologic patients after tumour progression itself. Patients suffering from malignancies are at increased risk for both venous (4-20...
Eligibility Criteria
Inclusion
- Consecutive pancreatic cancer patients undergoing pancreatic cancer resection in University Hospital of Larissa, after informed consent will be included.
Exclusion
- Refuse to participate
- Previous thromboembolic event \< 6 months prior to the operation
- History of inherited or acquired bleeding disorder
- ASA PS \> 3
- Concomitant presence of a second primary malignancy
- Unresectable pancreatic cancer
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05964621
Start Date
September 1 2023
End Date
October 1 2024
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Larissa
Larissa, Thessaly, Greece, 41110